Skip to content
Heavy Metal Index

Comparison of heavy metal regulations for herbal medicines across pharmacopoeias

Source

This paper compares the heavy metal regulatory limits for herbal medicines (Pb, Cd, Hg, As) as specified in nine major pharmacopoeias: Japanese (JP), European (EP), United States Pharmacopeia (USP), Chinese (ChP), Korean (KP), Taiwanese (TaiwanP), Indian (IP), British (BP), and the WHO guid...

Page snapshot
Cited by12 pages
Metals measured4
Evidence tierA
Year2023

Overview

This paper compares the heavy metal regulatory limits for herbal medicines (Pb, Cd, Hg, As) as specified in nine major pharmacopoeias: Japanese (JP), European (EP), United States Pharmacopeia (USP), Chinese (ChP), Korean (KP), Taiwanese (TaiwanP), Indian (IP), British (BP), and the WHO guidelines. The analysis reveals substantial variation in allowable limits across jurisdictions, with some pharmacopoeias applying much stricter thresholds than others for the same analytes and matrices.

Key numbers

The paper tabulates specific limit values for Pb, Cd, Hg, and As across all nine pharmacopoeia frameworks. Key findings include inter-jurisdictional variation of several-fold for the same metal across regulatory systems. The WHO guidelines generally set a baseline, with individual pharmacopoeias either adopting them directly or imposing tighter national standards. Specific numeric limits are provided by analyte and pharmacopoeia in the source tables.

Methods (brief)

Literature and regulatory document review; no experimental analytical measurement. Comparison is presented as a structured table of official published limits for each metal-pharmacopoeia combination.

Implications

Certification: Directly relevant to HMT&C international market positioning — brands selling herbal products into multiple jurisdictions face varying compliance thresholds. The strictest applicable limit governs.

Courses: Core reference for module on regulatory frameworks and global harmonisation of botanical supplement standards.

App: Useful for flagging jurisdiction-specific regulatory risk on herbal/botanical ingredient pages.

Microbiome: Not applicable.

Wiki pages updated on ingest

Update history

The five most recent substantive edits to this page, classified major (evidence or structure moved), correction (a published value or statement was wrong and has been fixed), or minor (narrative rewritten without changing the underlying evidence). Each description is derived from what the edit did to this page; the linked commit is the authoritative record, routine regeneration passes are excluded, and the full version history lives in git. When DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.

CommitDateChangeDescription
a8052bb2026-08-09major6 sections added; narrative text revised